Israeli Doctor Announces First COVID-19 Vaccine to Enter Phase 2 Testing
Cambridge, Massachusetts-based Moderna Therapeutics has received fast-track approval from the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine candidate, mRNA-1273. The company’s chief medical officer, Tal Zaks, M.D., Ph.D., has become a ubiquitous presence on American news programs